Nav: Home

Extending cervical screening beyond 5 years for some women is safe

October 04, 2016

Extending the cervical cancer screening interval beyond five years for women aged 40 and older who test negative for human papilloma virus (HPV) is safe, say researchers from the Netherlands in The BMJ this week.

Extending screening for women who test positive for HPV, however, is not recommended.

Trials have shown that screening for HPV leads to earlier detection of abnormal cells (known as cervical intraepithelial neoplasia or CIN) than cytology (smear) testing - and offers better protection against cervical cancer.

CIN is divided into grades - CIN1, 2 or 3. The higher the number, the more of the cervix is affected by abnormal cells.

Currently in the UK, women aged between 25 and 49 are invited for screening every three years, and up to the age of 64, every five years.

In the Netherlands, screening intervals for HPV negative women aged at least 40 years will be increased from five to 10 years in 2017.

But evidence on the safety of screening intervals beyond five years is limited. So a team of researchers based in the Netherlands decided to assess the safety of extending screening intervals beyond five years.

They base their findings on 14 year follow-up data from over 43,000 women aged 29-61 years who took part in a large trial of three cervical screening rounds (each round done every five years).

Women were randomly assigned to receive both HPV and cytology testing (intervention) or cytology testing only (control) and were managed according to their test results.

The data show that HPV negative women aged at least 40 have a very low risk of CIN3+ (the highest grade of abnormal cells) in the long term, "indicating that extension of the current screening interval in the Netherlands is justifiable," say the authors.

But they stress that for HPV positive women, the long term risk of CIN3+ is too high to support extending screening beyond five years.

The use of the HPV test result and age to define the year of next screen is a first step towards tailoring screening to individual risks - and could improve screening efficiency and eventually provide optimal prevention for all women, they write.

However, they point out that data on cervical cancer risk are inconclusive, and "therefore it remains important to closely monitor the number of interval cancers observed under the new HPV based screening programme."
Research: Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit


Related Cervical Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cost-effectiveness analysis of 12 cervical cancer screenings
This cost-effectiveness analysis incorporates women's preferences and estimates quality of life and economic outcomes for 12 cervical cancer screening strategies.
Urine test could prevent cervical cancer
Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists.
Cervical cancer subtype rising in some sub-populations
A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination
Cervical cancer is more aggressive when human papillomavirus is not detected
Cervical cancer negative for the human papillomavirus (HPV) is rare but more aggressive: it is more frequently diagnosed at advanced stages, with more metastasis and reduced survival.
More Cervical Cancer News and Cervical Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...